Veriti Thermal Cyclers

The Food and Drug Administration is forecasting the acquisition of Veriti Thermal Cyclers to replace aging equipment that has exceeded its expected service life of ten years and is at risk of failing upcoming calibration requirements. These thermal cyclers are essential for critical microbiological analyses, including whole genome sequencing and 16s sequencing, which support the agency’s scientific and regulatory functions. The procurement is classified under NAICS code 334516, indicating it pertains to laboratory equipment manufacturing, and is being managed by the FDA’s acquisition team, with direct inquiries routed to hfpacquisitions@fda.hhs.gov. While the solicitation is not yet active and the contracting officer has not been designated, the forecast signals an imminent need for replacement to ensure continuity in sequencing operations and compliance with instrument performance standards.